Company / Interest Expense
Integra Lifesciences Holdings Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$51.4M
FY2023
5-year range
$49.6M / $51.4M
FY2019-FY2023
Trend
+3.6%
vs FY2022
Sector context
#26 of 43
Health Care
What the data says
At $51M, Integra Lifesciences Holdings's interest expense ranks #18 of 43 in the Health Care sector. Interest Expense returned to growth in FY2023 after 2 years of decline, reaching $51M.
Based on SEC 10-K filings.
$51M in FY2023 with a 5-year CAGR of -4.5%.
Remained stable around $51M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -10.5%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $51.4M Sector average $324.8M
▼
-84.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.5%, indicating a declining trend.
- In FY2023, interest expense increased 3.6% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $51.4M | +3.6% |
| FY2022 | $49.6M | -1.6% |
| FY2021 | $50.4M | -29.6% |
| FY2020 | $71.6M | +32.7% |
| FY2019 | $54.0M | -16.6% |
| FY2018 | $64.7M | +174.8% |
| FY2017 | $23.5M | +7.1% |
| FY2016 | $22.0M | -6.7% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026